GlassScriptPhysician profile
Robert Strong Thornton
NPI 1851397855
$1,483.46
in general payments reported to CMS, 2019-2025
9 companies · $384 in 2025
The $384 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2021: $260 · 2022: $141 · 2023: $186 · 2024: $306 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772 · Education: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.43 |
| Education | $103.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $601.47 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $547.15 | 2019-2025 | Dupixent |
| Intersect Ent, INC. | $91.42 | 2021 | |
| Sanofi-Aventis U.S. LLC | $73.78 | 2019-2024 | |
| Glaxosmithkline, LLC. | $69.55 | 2025 | Nucala |
| Stryker Corporation | $36.20 | 2019 | |
| Itamar Medical INC | $32.67 | 2023-2025 | Watchpatone |
| Medtronic, INC. | $16.65 | 2025 | Ligasure |
| Aerin Medical INC. | $14.57 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Thornton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.